Seanergy Maritime (SHIP) - Shelf Offering Filed and Poison Pill Adopted
Seanergy Maritime (SHIP)
Shelf Offering Filed and Poison Pill Adopted
Seanergy Maritime Holdings Corp., an international shipping company, provides marine dry bulk transportation services through the ownership and operation of dry bulk vessels. Seanergy Maritime Holdings Corp. is the only pure-play Capesize shipping company listed in the US capital markets. Seanergy provides marine dry bulk transportation services through a modern fleet of 10 Capesize vessels, with total capacity of approximately 1,748,581 dwt and an average fleet age of about 9.8 years. The Company is incorporated in the Marshall Islands with executive offices in Athens, Greece and an office in Hong Kong. The Company's common shares trade on the Nasdaq Capital Market under the symbol "SHIP" and class A warrants under "SHIPW".
Poe Fratt, Senior Research Analyst, Noble Capital Markets, Inc.
Refer to the full report for the price target, fundamental analysis, and rating.
Mixed shelf offering for $300 million filed. After the market closed on Friday, a Form F-3 was filed. The mixed shelf offering adds the ability to issue $300 million of equity, preferred and/or debt. We view the shelf offering filing as a formality, or an updated version of the previous shelf offering filing, and do not believe that the any common shares will be issued unless the stock is well above the current stock price. It is also worth noting that financing is already in place to fund the latest acquisitions and the last equity offering was priced at $1.70/share (with no warrant overage) in February so near-term funding and liquidity are good.
No financials were included in the shelf offering, but the share count was updated. As of June 30, 2021, there were 168.5 million shares were outstanding, which means that no new shares have been issued since 1Q2021 operating results were released on May 25th ...
This research is provided by Noble Capital Markets, Inc., a FINRA and S.E.C. registered broker-dealer (B/D).
*Analyst certification and important disclosures included in the full report. NOTE: investment decisions should not be based upon the content of this research summary. Proper due diligence is required before making any investment decision.